NO174422C - Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater

Info

Publication number
NO174422C
NO174422C NO894103A NO894103A NO174422C NO 174422 C NO174422 C NO 174422C NO 894103 A NO894103 A NO 894103A NO 894103 A NO894103 A NO 894103A NO 174422 C NO174422 C NO 174422C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
analogous process
chromane derivatives
chromane
Prior art date
Application number
NO894103A
Other languages
English (en)
Norwegian (no)
Other versions
NO894103D0 (no
NO894103L (no
NO174422B (no
Inventor
Rolf Gericke
Manfred Baumgarth
Ingeborg Lues
Jacques De Peyer
Rolf Bergmann
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO894103D0 publication Critical patent/NO894103D0/no
Publication of NO894103L publication Critical patent/NO894103L/no
Publication of NO174422B publication Critical patent/NO174422B/no
Publication of NO174422C publication Critical patent/NO174422C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO894103A 1988-10-14 1989-10-13 Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater NO174422C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3835011A DE3835011A1 (de) 1988-10-14 1988-10-14 Chromanderivate

Publications (4)

Publication Number Publication Date
NO894103D0 NO894103D0 (no) 1989-10-13
NO894103L NO894103L (no) 1990-04-17
NO174422B NO174422B (no) 1994-01-24
NO174422C true NO174422C (no) 1994-05-04

Family

ID=6365113

Family Applications (1)

Application Number Title Priority Date Filing Date
NO894103A NO174422C (no) 1988-10-14 1989-10-13 Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater

Country Status (14)

Country Link
EP (1) EP0363883A1 (ja)
JP (1) JP2874912B2 (ja)
KR (1) KR0150780B1 (ja)
AR (1) AR247743A1 (ja)
AU (1) AU628395B2 (ja)
DE (1) DE3835011A1 (ja)
DK (1) DK511089A (ja)
FI (1) FI92825C (ja)
HU (1) HU217812B (ja)
IL (1) IL91967A0 (ja)
NO (1) NO174422C (ja)
NZ (1) NZ231000A (ja)
PT (1) PT91979B (ja)
ZA (1) ZA897783B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3726261A1 (de) * 1986-12-23 1988-07-07 Merck Patent Gmbh Chromanderivate
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
DE3924417A1 (de) * 1989-07-24 1991-01-31 Merck Patent Gmbh Chromanderivate
GB8924373D0 (en) * 1989-10-30 1989-12-20 Beecham Group Plc Novel compounds
DE4038752A1 (de) * 1990-12-05 1992-06-11 Merck Patent Gmbh Chromanderivate
JP3442815B2 (ja) * 1992-05-13 2003-09-02 第一製薬株式会社 ジアザビシクロアルケン誘導体
GB9316111D0 (en) * 1993-08-04 1993-09-22 Pfizer Ltd Benzopyrans
US5837702A (en) * 1993-10-07 1998-11-17 Bristol-Myers Squibb Co. 4-arylamino-benzopyran and related compounds
JP2001151767A (ja) * 1999-09-17 2001-06-05 Nissan Chem Ind Ltd ベンゾピラン誘導体
JP2001158780A (ja) * 1999-09-24 2001-06-12 Nissan Chem Ind Ltd 4−オキシベンゾピラン誘導体
JP2001172275A (ja) * 1999-10-05 2001-06-26 Nissan Chem Ind Ltd 4−オキシベンゾピラン誘導体
EP1940516A2 (en) * 2005-09-01 2008-07-09 Janssen Pharmaceutica, N.V. Benzopyran and pyranopyridine derivatives as potassium channel openers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8419515D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment
DE3726261A1 (de) * 1986-12-23 1988-07-07 Merck Patent Gmbh Chromanderivate
FR2615191B1 (fr) * 1987-05-16 1991-01-11 Sandoz Sa Nouveaux benzo(b)pyrannes et pyrannopyridines, leur preparation et leur utilisation comme medicaments
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
EP0346724A1 (de) * 1988-06-16 1989-12-20 MERCK PATENT GmbH Chromanderivate
DE3918041A1 (de) * 1989-06-02 1990-12-06 Merck Patent Gmbh Chromanderivate

Also Published As

Publication number Publication date
HU895311D0 (en) 1990-01-28
JP2874912B2 (ja) 1999-03-24
EP0363883A1 (de) 1990-04-18
KR900006326A (ko) 1990-05-07
PT91979A (pt) 1990-04-30
DK511089D0 (da) 1989-10-13
DE3835011A1 (de) 1990-04-19
FI894858A0 (fi) 1989-10-13
PT91979B (pt) 1995-05-31
AR247743A1 (es) 1995-03-31
KR0150780B1 (ko) 1998-10-15
AU628395B2 (en) 1992-09-17
ZA897783B (en) 1991-07-31
FI92825B (fi) 1994-09-30
JPH02145584A (ja) 1990-06-05
HU217812B (hu) 2000-04-28
NZ231000A (en) 1992-02-25
NO894103D0 (no) 1989-10-13
IL91967A0 (en) 1990-07-12
DK511089A (da) 1990-04-15
NO894103L (no) 1990-04-17
HUT58082A (en) 1992-01-28
FI92825C (fi) 1995-01-10
NO174422B (no) 1994-01-24
AU4256589A (en) 1990-04-26

Similar Documents

Publication Publication Date Title
NO174467C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
FI96861C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
NO176759C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater
NO179584C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler
FI92934B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi
NO176319C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive furanderivater
NO176275C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivater
NO178543C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzopyranderivater
NO178068C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive tiazolidindionderivater
NO903941D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater.
NO173334C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner
NO174391C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
NO174959C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater
FI884910A (fi) Menetelmä terapeuttisesti käyttökelpoisten bentsopyraanijohdannaisten valmistamiseksi
NO173784C (no) Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater
NO176477C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-alkoksymetylsubstituerte kromanderivater
NO174422C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
FI902727A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
NO176100C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive oksodihydropyridyl- og oksodihydropyridazinylkromanderivater
FI884660A0 (fi) Menetelmä terapeuttisesti aktiivisten 2,2-dimetyylikromeenijohdannaisten valmistamiseksi
NO178698C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive glycerolderivater
NO173607C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive tienotriazolo-diazepin-derivater
FI903077A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia
NO174203C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive
NO176099C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(2-okso-3-pyridyl)-kromanderivater